Tuesday, 17 October 2017

Pressure Monitoring to become More Convenient with Non-invasive Devices

Increasing pressure instabilities in vital parts of the body frequently lead to chronic conditions such as cardiac disorders, respiratory disorders, and glaucoma. This has led to high demand for pressure monitoring devices. 

Unhealthy lifestyle may result in high prevalence of cardiac disease. Hypertension is commonly observed among people with history of cardiac disorders, with high BP being the most common symptom. Therefore, BP monitoring devices exhibit high demand among these patients. 


Low level of oxygen in the blood may lead to problems such as increased shortness of breath and pulse rate and oxygen monitoring devices are highly required to monitor a patient’s oxygen level in the blood. 

Intracranial Pressure (ICP) monitoring plays an important role in diagnosing pressure related to the nervous system and blood vessel tissues to evade any harm to the brain. 

Glaucoma can be detected by determining eye pressure. Intraocular pressure (IOP) monitors are helpful to check IOP, which can change due to several factors such as a patient’s respiration and heart rate. 

Invasive Vs Non-invasive Blood Pressure Monitoring

Invasive Blood Pressure (IBP) monitoring or intra-arterial blood pressure monitoring is usually used in Intensive Care Units (ICU) and operating rooms. This technique includes direct arterial pressure measurement by inserting a cannula needle in the appropriate artery. This is connected to a sterile system filled with fluid, which is linked to an electronic patient monitor system. A patient’s blood pressure is observed beat by beat, displaying a waveform.

Non-invasive measurement methods are generally used for routine check-ups and monitoring. Non-invasive oscillometric and auscultatory methods are easier and faster than invasive measurements, need less proficiency in fitting, and are less painful for patients. However, non-invasive measures may have comparatively lower accuracy and may present minor variances in numerical results. 

Recently, Philips Healthcare developed a health watch that helps track heart rate and other metrics related to cardiac conditions and activities, even while sleeping. Users can obtain personalized information and guidance with the Philips Health Suite health app. Other products such as wrist and arm blood pressure monitors are also helpful for measuring blood pressure and heart rate. These systems are connected to the health app.

Market Overview

According to a report by Grand View Research, Inc., the global pressure monitoring market is predicted to value USD 11.9 billion by 2025. Blood pressure monitoring devices dominated the market in 2016 due to increasing prevalence of cardiac disorders and hypertension. In 2016, North America dominated the market. Asia Pacific is anticipated to exhibit lucrative growth during the forecast period (2014 to 2025) due to rising geriatric population in China.

Key players operating in the market include Medtronic, Philips Healthcare, GE Healthcare, Becton, and Welch Allyn.

To get free sample report at:

Flexible Offshore Mooring Systems Ensuring Optimization of Operations

Anchors hold ships and floating vessels stationed in deep waters. These vessels are confined from the movement of the water thanks to the mooring system, making this system an integral part of subsea production facilities. This system includes anchors, mooring line, and connectors. The mooring lines hold the anchor base on the sea or ocean floor, preventing the vessel from floating away.


Noah-FPSO Hull Supports Flexibility in Design

In April 2017, Mitsui Engineers & Shipbuilding Co., Ltd. was presented with the Bureau Veritas Approval in Principle (AIP) approval for “noah-FPSO Hull” and connected construction technique and design, in compliance with the American Bureau of Shipping. 

“New Offshore Adapted Hull” or “Noah” is an up-gradation of the conventional Floating Production, Storage, and Offloading (FPSO). The noah-FPSO allows a customizable approach to construction and design based on production needs, as compared to making changes in production facilities to suit the hull’s design.

The Noah-FPSO Hull brings with it unique features; for instance, the hull is compatible with other operational fields as a platform. This allows optimization of operations, maintenance, and the Engineering Procurement Construction and Installation (EPCI) process. This modular design is also compatible with a wide range of field requirements and this supports flexibility in design changes, which is common in FPSO endeavors. 

The hull has a wider deck, allowing the installation of heavier and complex topsides. It is made of 2-dimentional bending plates, which reduces construction costs and improves operability against green water or slamming loading. The steady aft/fore and parallel-body module with adjustable length can be manufactured at various shipyards. 

Mitsui has also launched “noah-Alliance” to provide speedy solutions for any challenges that can occur in these initiatives. This system will join any shipyard, globally, to construct the hulls with the help of the company’s services.

Market Insights

The offshore mooring systems market is projected to value USD 1.32 billion by 2025, according to a new study by Grand View Research, Inc. Rise in development of high-temperature gas hydrate basins can drive the market.

Mampaey Offshore Industries B.V., Single Point Mooring Systems, Offspring International, and ScanaIndustrier ASA. are key players in this market. These players provide components, system design, technology services, and planning to offshore oil and gas industries.

Monday, 16 October 2017

Electrodes for Medical Devices to Assure Accurate Diagnosis

An electrode is a solid electric conductor through which electric current enters or leaves an electrolytic cell, other medium, or the non-metallic part of a circuit. Electrodes used in medical devices convert ionic potential into electric signals and are generally made up of metal, lead, or gel. 


How They Work

The electrode used in medical devices transfers ionic current in the body and allows surface quantification of currents, which are amplified to diagnose several nervous, muscular, and cardiac disorders. 

Surface electrodes are aids to find bioelectric abilities from the surface of the body. For example, an electrocardiography (EEG) evaluates electric activity of the heart and needs 12 to 15 surface electrodes for diagnosis. 

Needle electrodes are inserted into the body to get localized measurement of potentials from a specific muscle. For example, an electromyography (EMG) uses a needle electrode to assesses muscular response to electrical activity of a specific muscle. 

Microelectrodes consist of small tips that can be penetrated through a single cell to take readings. 

Wireless Monitoring Pacemaker

Recently, Boston Scientific Corporation developed the “ESSENTIO MRI” and “ACCOLADE MRI” pacemakers, integrated with LATITUDE NXT patient management system. These provide wireless remote monitoring for speedier detection and intervention and improved patient outcomes. The Atrial Arrhythmia Report can be accessed using these pacemakers, which provides a complete view of the AT/AF status of a patient and any other information required for assessing the efficacy of AF treatment. 

A recent clinical study on the use of Remote Monitoring (RM) technology within cardiac rhythm devices exhibited that patients not under remote observation are at greater risk of mortality than those frequently tracked with automatic daily monitoring. 

Market Overview

Increasing prevalence of heart diseases and neurological disorders has resulted in extensive use of ECG and EEG devices, thereby driving demand for electrodes. According to a report by Grand View Research, Inc., the global electrodes for medical devices market is predicted to gain nearly USD 2.0 billion by 2025. 

North America is anticipated to dominate the market during the forecast period (2014 to 2025) due to increasing prevalence of CVDs. Prominent players in the market include GE Healthcare, 3M Healthcare, Boston Scientific Corporation, Medtronic, and Philips Healthcare.

To get free sample report at:

Improving Access to Healthcare Facilities to Benefit Uptake of Structural Heart Devices

Structural heart disease (SHD) is an umbrella term for various defects or abnormalities of the heart. This may include structural anomalies, functional abnormalities, congenital heart diseases, and acquired heart diseases. It was found that nearly 20% to 25%, or roughly 60 million, people in the U.S. have been diagnosed with SHD. 


An SHD is a non-coronary heart defect; this means that the disease does not affect blood vessels. The condition is often congenital, meaning that it is present since the time of birth. However, this defect can also be acquired later in life, caused due to wear and tear by infections. 

Boston Scientific Launches Permanent Implant Delivery Catheters  

The U.S. FDA recently approved an innovative technology called “Watchman LAA Closure Technology”, introduced by Boston Scientific. Watchman is a closure technology used as permanent implant delivery catheters. This helps avert Left Atrial Appendage (LAA) blood clots from entering the blood stream, causing strokes. The catheters have a self-inflating Nitinol or nickel-titanium frame. This frame has a woven plastic cap attached to it. 

The delivery catheter is inserted into a vein in the patient’s leg. Through the bloodstream, the catheter reaches the right atrium or the upper right heart chamber. A tiny incision is made in the wall between the two heart chambers. This incision allows the catheter to reach its destination – the LAA. 

The catheter is then pushed into the LAA, where it opens like an umbrella and is permanently fixed there. In around 45 days, a thin layer of tissue grows over the implant, preventing blood clot(s) from entering the bloodstream. This innovative device can be a boon for patients suffering from atrial fibrillation (AFib).

Market Insight

The global structural heart devices market can reach USD 9.1 billion by 2025, according to a new research by Grand View Research, Inc. The market is anticipated to grow at a 9.15% CAGR over the forecast period (2014 and 2025). Greater awareness, rigid screening, access to treatment, and support from governments across the globe can drive the market over the coming years. 

Key companies in the structural heart devices market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, and St. Jude Medical. These companies are often involved in mergers and acquisitions and developing new and innovative products to improve and strengthen their portfolio.

In-depth research report on structural heart devices market:
http://www.grandviewresearch.com/industry-analysis/structural-heart-devices-market

Friday, 13 October 2017

Blood Culture Tests become Quicker and More Accurate with Automated Techniques

Generally, blood does not contain any kind of bacteria or fungi. A blood culture test detects existence of bacteria, fungi, or microbiological infection in the blood. It is useful for treating several bacterial infections that spread into the blood in several circumstances such as osteomyelitis, meningitis, pneumonia, kidney infection, and sepsis.


Conventional Techniques Vs Automated Technologies

Standard blood culture bottles comprise one holding aerobic culture media and the other containing anaerobic media. Usually at least 10-15 mL of blood specimen should be collected using venepuncture and injected into blood culture bottles. For maximizing diagnostic yields of blood cultures, multiple sets of cultures may be taken by healthcare specialists. 

BioMérieux is a world leader in microbiology and considered to be a major player in in vitro diagnostics. The company has developed BacT/ALERT VIRTUO, which is a completely automatic blood culture system. It is easy to use and operates with load-and-go technology. The uploading of bottles is fully automated with visual and addible alarms. It offers powerful exclusive algorithms, high thermal stability, and superior optics, which increase performance and translate into faster detection of bloodstream infections.

Market Overview

According to Grand View Research, Inc., increasing frequency of bloodstream infections and infectious diseases is the most important aspect predicted to propel growth of the blood culture test market over the forecast period. The market value is estimated to reach USD 6.6 billion by 2025. Demand for advanced techniques to diagnose infectious diseases and conditions like sepsis is another key driving factor. Automated blood culture systems are predicted to form the fastest growing segment due to the accuracy and efficiency they offer. Reference laboratories are anticipated to grow rapidly due to outsourcing of blood tests by hospitals. 

With well-developed infrastructure, North America is the leading regional market and accounted for the largest market share in 2016. Asia Pacific is estimated to grow at the highest CAGR during the forecast period due to high incidence of infectious diseases and presence of refining healthcare and R&D infrastructures. 

Some of the major players operating in the blood culture test market are Becton, Dickinson and Company; Thermo Fisher Scientific, Inc.; bioMérieux SA; Danaher Corporation; Roche Diagnostics; and Bruker Corporation.

To get free sample request at:

Monday, 9 October 2017

Single-use Systems to Ensure Safety and Efficiency of Pharmaceutical Filtration Systems

The need for vaccines and drugs to treat high-risk diseases has created a vacuum of efficient filtration systems. Pharmaceutical filtration systems are used by major pharmaceuticals to produce drugs on a large scale.


Rising Need in Drug Discovery & Development


Pharmaceutical filtration is a vital step in drug manufacturing in major pharmaceuticals. It can aid companies by reducing production costs. Bioprocess filters can be applied to small and large batches of bioreactors. They can provide options for usage of cell media, desired operating temperature, and required scale of operation. 

The trend of customized medicines, development of drugs to target smaller patient pools, and need for local manufacturing are pushing the demand for these filtration systems. Single-use systems are being highly preferred by pharmaceutical companies to avoid chances of contamination.

The Next Big Thing in Filtration Systems 


Sartorium Stedim Biotech, one of the leaders in the biopharmaceutical industry, has launched an enhanced version of its Sartocon filtration system, embedded with a polyether sulfone membrane. It can be used in monoclonal antibody manufacturing, small-scale batches, and clinical trials.

Millipore Sigma, a division of Merck KGaA, has launched single-use filters and capsules to ensure efficiency among biopharmaceutical manufacturers. The M-shaped filters have increased capacity in plugging feed streams and enhancing reliability of single-use systems.

Market Overview


The worldwide pharmaceutical filtration market is expected to exceed USD 37 billion by 2025, according to Grand View Research, Inc. It is driven by expansion of the biopharmaceutical industry and need for advanced filters to produce vaccines on a large scale. Prevalence of chronic diseases such as rheumatic arthritis, heart disease, and cancer is also expected to spur demand over the forecast period (2014 – 2025).

Membrane filters accounted for a major market share in 2016 due to their varied applications. Single-use systems are anticipated to exhibit a significant growth rate during the forecast period on account of low production time and low contamination rate associated with these filters. The Asia Pacific market is anticipated to grow at a lucrative rate on account of lax regulations as well availability of a large genome pool. Notable market players include 3M, Merck KGaA, Parker Hannifin Corporation, and Danaher Corporation.

Thursday, 5 October 2017

Artificial Intelligence in Ecommerce and the Futuristic Transformation So Far

For the longest time, artificial intelligence (AI) was a concept that existed merely in novels and movies and this fascinated users to no end. As the technology made a more mainstream entrance, the industrial sector was one of the first to benefit from its many features, including mitigating workload of laborers and lowering costs. Even then, the extent of AI’s impact had not been fully gauged.


Today, artificial intelligence has made its way into our homes and has integrated itself into our day-to-day activities, especially shopping. The inclusion of artificial intelligence in the ecommerce sector has the potential to revolutionize the way consumers shop online. Business Insider states that by 2020, a whopping 85% of customer interactions will be done without a human. 

Virtual Assistants as Your New Personal Shopper

The three major aspects that AI brings to the ecommerce table are access to computing power, Big Data, and an army of virtual assistants. By using natural language processing (NLP), machine learning, and Deep Learning languages, it can address and respond to human queries. Well-known examples of virtual assistants in today’s technology-driven world include voice assistants like Alexa or Siri.

Easy access to the Internet as well as prolific use of hand-held, connected, and smart devices by consumers is making it easier for chatbots to collate customer data, browser history, previous preferences, shopping behavior patterns, etc. and play the role of a helpful digital personal shopper. 

Retail companies with a strong online presence can provide a more personalized shopping experience for their customers. By gathering actionable sales intelligence with respect to client behavior, companies can engage with their customers in an extremely impactful manner.

The Growing Business of Artificial Intelligence 

Artificial intelligence technology is being extensively deployed by a number of online and mobile services such as dialogue and voice recognition of Siri, the Google Assistant, image classification in Facebook & Google Photo, Microsoft Cortana, and Amazon’s Alexa. As more and more players in the ecommerce industry turn to AI as an effective tool to attract new and potential customers, artificial intelligence as a business will continue to soar. Grand View Research predicts that the AI market will cross the US$ 35 billion-mark by 2025.

Recently, Flipkart decided to collaborate with Microsoft in order to double its sales and revenue figures using AI. Taking a leaf out of Flipkart’s book, online shopping portals and companies can rely on artificial intelligence to provide a more customized experience and make transactions smoother. Social media patterns can also be used to offer suggestions to consumers based on their likes and dislikes. This also helps filter out annoying advertisements and other promotional mails that force a consumer to make a purchase.

AI is also being combined with recent image search technologies to search for products accurately. In fact, mobile apps such as Snapchat and Pinterest have been able to capitalize on this to provide customers with accurate data. Getty Images is another case in point. Correct tagging of images can lead to astute consumer suggestions as well as play an integral role in developing predictive analytics further.

Few industries are as competitive as ecommerce and as consumer attention continues to get shorter, retail companies in cyberspace are looking for ways to encourage customers to buy what’s in their shopping cart rather than abandon it. Artificial intelligence seems to be the answer they’re looking for.


For more information visit @ www.grandviewresearch.com